Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
17 angezeigte Treffer · Seite 3, keine Gesamtzahl für „Aubagio“
Suchtreffer
Begriffe & Kennungen
Aubagio · 4.8 · Infections In placebo-controlled studies in adult patients, no increase in serious infections was observed wit
Eintrag öffnenAubagio · 4.8 · Listed below are the adverse reactions reported with AUBAGIO in placebo-controlled studies in adult patients,
Eintrag öffnenAubagio · 4.8 · Mild increases in transaminase, ALT below or equal to 3-fold ULN were more frequently seen in teriflunomide-tr
Eintrag öffnenAubagio · 4.8 · Neoplasms benign, malignant and unspecified (incl. cysts and polyps) There does not appear to be an increased
Eintrag öffnenAubagio · 4.8 · Paediatric population
Eintrag öffnenAubagio · 4.8 · Peripheral neuropathy In placebo-controlled studies in adult patients, peripheral neuropathy, including both p
Eintrag öffnenAubagio · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnenAubagio · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenAubagio · 4.8 · Severe skin reactions Cases of severe skin reactions have been reported with teriflunomide post-marketing (see
Eintrag öffnenAubagio · 4.8 · Summary of the safety profile
Eintrag öffnenAubagio · 4.8 · System organ Very Common Uncommon Rare Very Not known class common rare Infections and Influenza, Upper Severe
Eintrag öffnenAubagio · 4.8 · Tabulated list of adverse reactions Teriflunomide was evaluated in a total of 2,267 patients exposed to terifl
Eintrag öffnenAubagio · 4.8 · Teriflunomide is the main metabolite of leflunomide. The safety profile of leflunomide in patients suffering f
Eintrag öffnenAubagio · 4.8 · The following adverse reactions were more frequently reported in the paediatric population than in the adult p
Eintrag öffnenAubagio · 4.8 · The most frequently reported adverse reactions in the teriflunomide treated (7 mg and 14 mg) patients were: he
Eintrag öffnenAubagio · 4.8 · The observed safety profile in paediatric patients (from 10 to 17 years-old) receiving teriflunomide daily was
Eintrag öffnenAubagio · 4.8 · a : please refer to the detailed description section b : see section 4.4 c : frequency is “common” in children
Eintrag öffnen